SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-005706
Filing Date
2024-08-14
Accepted
2024-08-14 16:45:46
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 2024 phio_i10q-063024.htm   iXBRL 10-Q 596922
2 CERTIFICATION phio_ex3101.htm EX-31.1 9496
3 CERTIFICATION phio_ex3102.htm EX-31.2 9076
4 CERTIFICATION phio_ex3201.htm EX-32.1 3894
5 CERTIFICATION phio_ex3202.htm EX-32.2 3723
  Complete submission text file 0001683168-24-005706.txt   3454763

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE phio-20240630.xsd EX-101.SCH 28878
7 XBRL CALCULATION FILE phio-20240630_cal.xml EX-101.CAL 33191
8 XBRL DEFINITION FILE phio-20240630_def.xml EX-101.DEF 126687
9 XBRL LABEL FILE phio-20240630_lab.xml EX-101.LAB 278903
10 XBRL PRESENTATION FILE phio-20240630_pre.xml EX-101.PRE 233323
56 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10q-063024_htm.xml XML 390296
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 241209002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)